FDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not Younger

By | September 18, 2021

[unable to retrieve full-text content]FRIDAY, Sept. 17, 2021 — An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for…
Drugs.com – Daily MedNews

Read More:  As Deaths Mount, Coronavirus Testing Remains Wildly Inconsistent In Long-Term Care